Study: Slimming medicine can reduce the risk of Alzheimer's, addiction and heart disease

Scientists have revealed that there is a relationship between the consumption of people with weight loss medications and the benefits of cognitive and behavioral health, but it also showed an increase in the risk of pancreatitis and kidney disease. Scientists at the Faculty of Medicine at the University of Washington and the healthcare system of the Ministry of Old Warriors issues evaluated the health results of more than two million diabetics who have famous weight loss medications. According to the study published in the journal “Nature Medicine”, new slimming medicine was associated with great benefits for neurological and behavioral health, with a lower risk of attacks and addiction to substances such as alcohol, hemp, stimulants and ovens. People who took weight loss medicine were also a decrease in the risks of suicide ideas, self -warming, pathological disorders and psychotic disorders such as schizophrenia, and the results showed a decrease in the risk of cognitive nervous disorders such as Alzheimer’s and dementia. In recent years, the demand for weight loss medication has had a noticeable increase, which sheds light on medications such as “Montarua” and “Zepopond”, officially known as GLP-1RA inhibitors. “Miracle Medicines” and these medications were originally developed to treat type 2 diabetes, but they received a lot of attention because of their ability to significantly increase weight loss, which led to the nickname “Miracle Medicines”. Patients and some healthcare providers have priced the effectiveness of these medicines in weight treatment and metabolic diseases. However, despite the well -known benefits of this medicine, information on its effects on different body systems remains limited. And the brushers of the brick-like glucagon 1 peptide 1, a group of medication aimed at simulating the effects of a natural hormone called GLP-1. This hormone plays a major role in regulating blood sugar levels by stimulating insulin secretion in response to meals, the prevention of glucagon secretion, a hormone that increases the sugar in the blood, slows down the emptying of the stomach, increasing the feeling of saturation, which increases the penchant for controlling the control of blood control. The benefits of this medication exceed mere weight loss; In addition to helping to manage weight, it is effective to control blood sugar levels, making it especially useful for patients with type 2 diabetes. By improving insulin allergy and reducing the risk of high blood sugar, GLP-1RA helps to prevent long-term complications of diabetes such as heart disease, nerve damage and renal failure. In addition, studies have shown that this medication can improve heart health by reducing the risk of heart attacks, strokes and other cardiovascular problems, and this has led to their prescription, not only for diabetes and obesity, but also as a way to prevent the risk of cardiovascular and blood vessels. Brain health is initial research that new slimming medicine benefits for brain health, especially to reduce the risk of Alzheimer’s and dementia. It is believed that this medication has a positive effect on the brain by reducing infections and improving neurological effects. In the new study; The researchers investigated the data of more than 2 million old warriors treated from diabetes between October 1, 2017 and December 31, 2023, and patients included people of different ages, ethnicities and gender. The researchers have prepared an extensive map that has the effects of these medications on all body systems, including the heart, kidneys, brain, nervous and digestive system, analyzed by collecting comprehensive medical data from a large group of patients and analyzing how medication affects different parts of the body, whether positive, such as an improved neurological health, or negative. The recent study has shown that the medicine is not limited to improving blood sugar levels and reducing weight, but also extends to a wide range of other health benefits that contribute to the promotion of public health. Among these benefits, the results showed that medication positively affects neurological and behavioral health, as a significant improvement in the risks associated with spasms and addiction, such as addiction to alcohol and drugs. In addition, the researchers have noted a decrease in the risk of mental disorders such as schizophrenia, which indicates the ability of medication to improve mental health in general. These neurological and behavioral benefits are an important step towards achieving a comprehensive balance of health for the body, and not just by influencing physical aspects such as weight and blood sugar level. A decrease in the risk of Alzheimer’s, and the study showed positive effects on degenerative neurological diseases. A significant decrease has been monitored in the risk of diseases such as dementia and Alzheimer’s, which reflects the improvement that can achieve medication in the function of the brain. The researchers believe that these effects are due to the role of medication in reducing encephalitis and improving the immune response, which contributes to the promotion of brain health and reducing the possibilities of developing neurological diseases associated with aging. The researchers said that this discovery is an important addition to psychiatry and nerve medicine, and increases the belief that new slimming medicine can open a new horizon in the prevention and treatment of diseases that affect memory and thinking. In the field of cardiovascular health, it has been confirmed that this medication contributes to reducing the risk of heart disease, such as heart attacks and strokes. The researchers pointed out that the effect of medication is linked to improving cholesterol and blood pressure, which are two most important factors to prevent heart disease. Studies have also shown the ability of medication to reduce the risk of addiction, as it has been found to help reduce the desires of individuals to addictions such as alcohol and drugs. This effect is believed to occur through the effect of medication on the reward centers in the brain, reducing the desire to take these substances and contributes to improving the behavior of individuals. This discovery is an important step towards using medication as part of addicted treatment strategies that depend on the adjustment of individuals’ behavior in dealing with addiction. Health risks, although slimming medicine showed many health benefits, but the study also revealed some unknown health risks that should be under careful supervision. One of the most important of these risks is to increase the risk of pancreatic disease, as it has been noted that using this medicine may increase the risk of pancreatitis, which is one of the possible complications that require accurate follow -up to doctors. The researchers pointed out that doctors should be aware of these risks and take the necessary measures to detect them early and reduce its effects. Regarding the effects of medication on kidney function, the study revealed some symptoms with kidney problems. Although these cases are rare, its effects can be severe, as kidney damage can occur without noticeable symptoms to advanced stages, making it necessary to pursue kidney function periodically in patients taking this medication. It has also been shown that some patients may suffer from unwanted symptoms, such as nausea, vomiting and diarrhea, which are common when using medication. In rare cases, medication can lead to stomach paralysis, which requires a strong medical follow -up. Therefore, according to the study; Doctors should inform patients about possible risks and should direct how to handle side effects, especially in cases of acute digestive problems. “It is interesting that the GLP-1RA medicine works on the receptors expressed in the brain areas participating in the control of the pulses, benefits and addiction, which declares its effectiveness in reducing appetite disorders and addiction,” the lead author of the study, “Ziad Al-Ali” and director of the clinical epidemiological center in the health care system. Al -Ali indicated that these drugs also reduced inflammation in the brain and lead to weight loss; The two factors can improve brain health and reduce the risk of diseases such as Alzheimer’s and dementia.